Pseudomyxoma peritonei

British Journal of Surgery

Volumn 85, Issue 10, 1998, Pages 1332-1339

  Hinson, F L ^a   Ambrose, N S ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MELPHALAN; MITOMYCIN C; MUCOLYTIC AGENT; TUMOR MARKER;

ABDOMINAL RADIOGRAPHY; ADJUVANT CHEMOTHERAPY; APPENDIX CARCINOMA; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MEDICAL LITERATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OMENTUM; PERITONEUM PSEUDOMYXOMA; PHOTOTHERAPY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE THERAPY; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; EXPECTORANTS; HUMANS; HYPERTHERMIA, INDUCED; MAGNETIC RESONANCE IMAGING; PHOTOTHERAPY; PROGNOSIS; PSEUDOMYXOMA PERITONEI; RECURRENCE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031672007     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1998.00882.x     Document Type: Article

References (86)

1. Mann WJ Jr, Wagner J, Chumas J, Chalas E. The management of pseudomyxoma peritonei. Cancer 1990; 66: 1636-40.
2. Fann JI, Vierra M, Fisher D, Oherhelman HA Jr, Cobb L. Pseudomyxoma peritonei. Surg Gynecol Obstet 1993; 177: 441-7.
3. Weaver CH. Mucocele of appendix with pseudomucinous degeneration. Am J Surg 1937; 36: 523-6.
4. Werth R. Klinische und Anatomische Untersuchungen zur Lehre von den Bauchgeschwullsten und der Laparotomie. Arch Gynecol Obstet 1884; 24: 100-18.
5. Frankel E. Uber das sogenannte pseudomyxoma peritonei. Med Wochenschr 1901; 48: 965-70.
6. Mann CV. The peritoneum, omentum, mesentery and retroperitoneal space. In: Mann CV, Russell RCG, Williams NS, eds. Bailey and Love's Short Practice of Surgery. 22nd ed. London: Chapman and Hall, 1995: 64-80.
7. Barr H. Pseudomyxoma peritonei. In: Morris PJ, Malt RA, eds. Oxford Textbook of Surgery. Vol. I. Oxford: Oxford University Press, 1994: 1120-1.
8. Byron RL Jr, Yonemoto RH, King RM, Lamb EJ, Amromin GD, Solomon RD et al. The management of pseudomyxoma peritonei secondary to ruptured mucocoele of the appendix. Surg Gynecol Obstet 1996; 122: 509-12.
9. Sandenbergh HA, Woodruff JD. Histogenesis of pseudomyxoma peritonei. Review of 9 cases. Obstet Gynecol 1977; 49: 339-45.
10. Cheng KK. An experimental study of mucocoele of the appendix and pseudomyxoma peritonei. J Pathol Bacteriol 1949; 61: 217-25.
11. Carr NJ, McCarthy WF, Sobin LH. Epithelial noncarcinoid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer 1995; 75: 757-68.
12. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to 'pseudomyxoma peritonei'. Am J Surg Pathol 1995; 19: 1390-408.
13. Carr NJ. Pseudomyxoma peritonei and the cytologist. Cytopathology 1996; 7: 288 (Letter).
14. Young RH, Gilks CB, Scully RE. Pseudomyxoma peritonei. Am J Surg Pathol 1993; 17: 1068-71 (Letter).
15. Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA. Association of mucinous tumors of the ovary and appendix. A clinicopatholoeic study of 25 cases. Am J Surg Pathol 1993; 17: 22-34.
16. Kahn MA, Demopoulos RI. Mucinous ovarian tumors with pseudomyxoma peritonei: a clinicopatholoaical study. Int J Gynecol Pathol 1992; 11: 15-23.
17. Kaern J, Trope CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer 1993; 71: 1810-20.
18. Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991; 15: 415-29.
19. Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994; 18: 591-603.
20. Ronnett BM, Kurman RJ, Zahn CM, Shmookler BM, Jablonski KA, Kass ME et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1945; 26: 509-24.
21. Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 1997; 16: 1-9.
22. Guerrieri C, Franlund B, Boeryd B. Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix. Mod Pathol 1995; 8: 573-6.
23. Ueda G, Sawada M, Ogawa H, Tanizawa O, Tsujimoto M. Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary. Gynecol Oncol 1993; 51: 219-23.
24. Cuatrecasas M, Matias-Guiu X, Prat J. Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol 1996; 20: 739-46.
25. Chuaqui RF, Zhuang Z, Emmert-Buck MR, Bryant BR, Nogales F, Tavassoli FA et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol 1996; 27: 165-71.
26. Costa MJ. Pseudomyxoma peritonei. Histologic predictors of patient survival. Arch Pathol Lab Med 1994; 118: 1215-19.
27. Kurita M, Komatsu H, Hata Y, Shiina S, Ota S, Terano A et al. Pseudomyxoma peritonei due to adenocarcinoma of the lung: creport. J Gastraenterol 1994; 29: 344-8.
28. Hawes D, Robinson R, Wira R. Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast. Gastrointest Radiol 1991; 16: 80-2.
29. Chejfec G, Rieker WJ, Jablokow VR, Gould VE. Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas. Gastroenterology 1986; 90: 202-5.
30. Ikejiri K, Anai H, Kitamura K, Yakabe S, Saku M, Yoshida K. Pseudomyoxoma peritonei concomitant with early gastric cancer: report of a case. Surg Today 1996; 26: 923-5.
31. Young RH, Scully RE. Ovarian metastases from carcinoma of the gallbladder and extrahepatic bile ducts simulating primary tumors of the ovary. A report of six cases. Int J Gynecol Pathol 1990; 9: 60-72.
32. McCarthy JH, Aga R. A fallopian tube lesion of borderline malignancy associated with pseudo-myxoma peritonei. Histopathology 1988; 13: 223-5.
33. Friedmann W, Minguillon C, Wessel J, Lichtenegger W, Pickel H. Pseudomyxoma peritonei durch ein proliferierendes muzinoses Adenom der Fimbrienschleimhaut. Geburtshilfe Frauenheilkd 1990; 50: 579-80.
34. Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR. Wilson TO et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994; 219: 112-19.
35. Baker WC, Goldman LB, deVere White RW. Pseudomyxoma peritonei presenting as a scrotal mass. J Urol 1988; 139: 821-2.
36. Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D et al. Pseudomyxoma peritonei syndrome. Adv Surg 1996; 30: 233-80.
37. Sugarbaker PH. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 1994; 219: 109-11 (Editorial).
38. Matsuoka Y, Ohtomo K, Itai Y, Nishikawa J, Yoshikawa K, Sasaki Y. Pseudomyxoma peritonei with progressive calcifications: CT findings. Gastrointest Radiol 1992; 17 16-18.
39. Buy JN, Malbec L, Ghossain MA, Guinet C, Ecoiffier J. Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol 1989; 9: 115-18.
40. Yeh HC, Shafir MK, Slater G, Meyer RJ, Cohen BA, Geller SA. Ultrasonography and computed tomography in pseudomyxoma peritonei. Radiology 1984; 153: 507-10.
41. Seshul MB, Coulam CM. Pseudomyxoma peritonei: computed tomography and sonography. AJR Am J Roentgenol 1981; 136: 803-6.
42. Walensky RP, Venbrux AC, Prescott CA, Osterman FA Jr. Pseudomyxoma peritonei. AJR Am J Roentgenol 1996; 167: 471-4.
43. Balthazar EJ, Javors BR. The radiology corner. Pseudomyxoma peritonei: clinical and radiographic features. Am J Gastroenterol 1977; 68: 501-9.
44. Pugh DG. A roentgenologic aspect of pseudomyxoma peritonei. Radiology 1942; 39: 320-2.
45. Bhutani MS, Barde CJ. Endosonographic findings in pseudomyxoma peritonei. Endoscopy 1996; 28: 459.
46. Hameed A, Jafri N, Copeland LJ, O'Toole RV. Endometriosis with myxoid change simulating mucinous adenocarcinoma and pseudomyxoma peritonei. Gynecol Oncol 1996; 62: 317-19.
47. Pfitzer P, Richartz G. Cytology of pseudomyxoma peritonei. Cytopathology 1995; 6: 304-15.
48. Gupta RK, Naran S. Cytodiagnosis of pseudomyxoma peritonei in cases suspected of ovarian tumours. Diagn Cytopathol 1993; 9: 682-4.
49. Mulvany N, Ooi K. Pseudomyxoma peritonei: a cytohistopathologic study of nine cases. Diagn Cytopathol 1996; 15: 144-50.
50. Costa M, Oertel YC. Cytology of pseudomyxoma peritonei: report of two cases arising from appendiceal cystadenomas. Diagn Cytopathol 1990; 6: 201-3.
51. Leiman G, Goldberg R. Pseudomyxoma peritonei associated with ovarian mucinous tumors. Cytologic appearance in five cases. Acta Cytol 1992; 36: 294-304.
52. Pisharodi LR, Bedrossian C, Gudlaugsson E. Cytologic diagnosis of pseudomyxoma peritonei: common and uncommon causes. Int J Surg Pathol 1995; 2(Suppl): 101.
53. Clement PB, Granai CO, Young RH, Scully RE. Endometriosis with myxoid change. A case simulating pseudomyxoma peritonei. Am J Surg Pathol 1994; 18: 849-53.
54. Zoetmulder FA, Sugarhaker PH. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer 1996; 32A: 1727-33.
55. Landen S, Bertrand C, Maddern GJ, Herman D, Pourbaix A, de Neve A et al. Appendiceal mucoceles and pseudomyxoma peritonei. Surg Gynecol Obstet 1992; 175: 401-4.
56. Nasr MF, Kemp GM, Given FT Jr. Pseudomyxoma peritonei: treatment with intrapcritoneal 5-fluorouracil. Eur J Gynaecol Oncol 1993; 14: 213-17.
57. Friedland JS, Allardice JT, Wyatt AP. Pseudomyxoma peritonei. J R Soc Med 1986; 79: 480-2.
58. Limber GK, King RE, Silverberg SG. Pseudomyxoma peritonei: a report of ten cases. Ann Surg 1973; 178: 587-93.
59. Sugarbaker PH. Pseudomyxoma peritonei. Cancer Treat Res 1996; 81: 105-19.
60. Wertheim I, Fleischhacker D, McLachlin CM, Rice LW, Berkowitz RS, Golf BA. Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol 1994; 84: 17-21.
61. Sudhindran S, Varghesc CJ, Ramesh H. Pseudomyxoma peritonei: a report of eight cases. Indian J Gastroenterol 1994; 13: 137-8.
62. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221: 29-42.
63. Sugarbaker PH, Kern K, Lack E. Malignant pseudomyxoma peritonei of colonie origin. Natural history and presentation of a curative approach to treatment. Dis Colon Rectum 1987; 30: 772-9.
64. Green N, Gancedo H, Smith R, Bernett G. Pseudomyxoma peritonei - non operative management and biochemical findings. A case report. Cancer 1975; 36: 1834-7.
65. Carter J, Moradi MM, Elg S, Byers L, Adcock LA, Carson LF et al. Pseudomyxoma peritonei - experience from a tertiary referral centre. Aunt N Z J Obstet Gynaecol 1991; 31: 177-8.
66. Piver MS, Lele SB, Patsner B. Pseudomyxoma peritonei: possible prevention of mucinous ascites by peritoneal lavage. Obstet Gynecol 1984; 64(Suppl 3): 95-6s.
67. Shyr YM, Su CH, Wang HC, Lo SS, Lui WY. Pseudomyxoma peritonei: does a true mucolytic agent exist? In vitro and in vivo studies. Am Surg 1995; 61: 265-70.
68. Roy WJ Jr, Thomas BL, Horowitz IR. Acute hyperglycemia following intraperitoneal irrigation with 10% dextrose in a patient with pseudomyxoma peritonei. Gynecol Oncol 1997; 65: 360-2.
69. Sindelar WF, DeLaney TF, Tochner Z, Thomas GF, Dachoswki LJ, Smith PD et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg 1991; 126: 318-24.
70. Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980; 40: 256-60.
71. Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1992; 70: 396-401.
72. Sugarbaker PH. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 1995; 19: 235-40.
73. Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi SS, Konno C et al. Pharmocokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far advanced or recurrent gastric cancer. Reg Cancer Treat 1989; 2: 198-202.
74. Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 1990; 50: 5790-4.
75. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumour cells. Cancer Res 1981; 41: 1096-9.
76. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979; 39: 2264-8.
77. Yonemura Y, Fujimura T, Nishimura G, Falla R, Sawa T, Katayama K et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996; 119: 437-44.
78. Sugarhaker PH, Landy D, Jaffe G, Pascal R. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis and cystadenocarcinoma of the colon or appendix. Cancer 1990; 65: 1495-501.
79. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-32.
80. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T, Isawa E et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997; 79: 884-91.
81. Fernandez RN, Daly JM. Pseudomyxoma peritonei. Arch Surg 1980; 115: 409-14.
82. Long RT, Spratt JS Jr, Dowling E. Pseudomyxoma peritonei. New concepts in management with a report of seventeen patients. Am J Surg 1980; 117: 162-9.
83. el Sayed S. Pseudomyxoma peritonei treated by radiotherapy. Clin Oncol R Coll Radiol 1990; 2: 120-2.
84. Kairemo KJ. Radioimmunotherapy of solid cancers: a review. Acta Oncol 1996; 35: 343-55.
85. Jahne J, Lang H, Meyer HJ, Pichlmayr R. Moglichkeiten und Grenzen der chirurgischen Therapie des Pseudomyxoma peritonei. Langenbecks Arch Chir 1993; 378: 292-6.
86. Yaqoob M, Final IH, Finn R. Obstructive nephropathy due to pseudomyxoma peritonei and its management by cystic obliteration and urinary diversion. Nephrol Dial Transplant 1991; 6: 60-1.